BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25546417)

  • 21. Cationic trypsinogen mutations and pancreatitis.
    Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
    Gastroenterol Clin North Am; 2004 Dec; 33(4):767-87. PubMed ID: 15528017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copy number variations in chronic pancreatitis.
    Chen JM; Masson E; Le Maréchal C; Férec C
    Cytogenet Genome Res; 2008; 123(1-4):102-7. PubMed ID: 19287144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hereditary pancreatitis].
    Lee SK
    Korean J Gastroenterol; 2005 Nov; 46(5):358-67. PubMed ID: 16301849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation That Promotes Activation of Trypsinogen Increases Severity of Secretagogue-Induced Pancreatitis in Mice.
    Jancsó Z; Sahin-Tóth M
    Gastroenterology; 2020 Mar; 158(4):1083-1094. PubMed ID: 31751559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discrimination of three mutational events that result in a disruption of the R122 primary autolysis site of the human cationic trypsinogen (PRSS1) by denaturing high performance liquid chromatography.
    Le Maréchal C; Chen JM; Quéré I; Raguénès O; Férec C; Auroux J
    BMC Genet; 2001; 2():19. PubMed ID: 11734061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of R122H mutation of cationic trypsinogen gene in a pediatric patient with hereditary pancreatitis complicated by pseudocyst and hemosuccus pancreaticus].
    Kim JY; Choi SH; Ihm JS; Kim SJ; Kim IJ; Kim CM
    Korean J Gastroenterol; 2005 Feb; 45(2):130-6. PubMed ID: 15725718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism.
    Kereszturi E; Szmola R; Kukor Z; Simon P; Weiss FU; Lerch MM; Sahin-Tóth M
    Hum Mutat; 2009 Apr; 30(4):575-82. PubMed ID: 19191323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local clustering of PRSS1 R122H mutations in hereditary pancreatitis patients from Northern Germany.
    Weiss FU; Zenker M; Ekici AB; Simon P; Mayerle J; Lerch MM
    Am J Gastroenterol; 2008 Oct; 103(10):2585-8. PubMed ID: 18702646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Pathogenic
    Jancsó Z; Oracz G; Kujko AA; Kolodziejczyk E; Radisky ES; Rygiel AM; Sahin-Tóth M
    Front Genet; 2019; 10():46. PubMed ID: 30792736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis.
    Jancsó Z; Sahin-Tóth M
    J Biol Chem; 2016 Jun; 291(25):12897-905. PubMed ID: 27129265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low penetrance pancreatitis phenotype in a Venezuelan kindred with a PRSS1 R122H mutation.
    Solomon S; Gelrud A; Whitcomb DC
    JOP; 2013 Mar; 14(2):187-9. PubMed ID: 23474566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The course of genetically determined chronic pancreatitis.
    Keim V; Witt H; Bauer N; Bodeker H; Rosendahl J; Teich N; Mossner J
    JOP; 2003 Jul; 4(4):146-54. PubMed ID: 12853682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRSS1 (R122H) mutation in an Indian family with low penetrance is associated with pancreatitis phenotype.
    Avanthi US; Bale G; Aslam M; Talukdar R; Duvvur NR; Vishnubhotla RV
    Indian J Gastroenterol; 2018 Jan; 37(1):67-69. PubMed ID: 29476405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 --> Cys) that alters autoactivation and autodegradation of cationic trypsinogen.
    Simon P; Weiss FU; Sahin-Toth M; Parry M; Nayler O; Lenfers B; Schnekenburger J; Mayerle J; Domschke W; Lerch MM
    J Biol Chem; 2002 Feb; 277(7):5404-10. PubMed ID: 11719509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis.
    Chen JM; Piepoli Bis A; Le Bodic L; Ruszniewski P; Robaszkiewicz M; Deprez PH; Raguenes O; Quere I; Andriulli A; Ferec C
    Clin Genet; 2001 Mar; 59(3):189-93. PubMed ID: 11260229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cationic trypsinogen mutations and pancreatitis.
    Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
    Clin Lab Med; 2005 Mar; 25(1):39-59. PubMed ID: 15749231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological features of patients with chronic pancreatitis due to mutations in the PRSS1 gene: evaluation of BRAF and KRAS2 mutations.
    Felderbauer P; Stricker I; Schnekenburger J; Bulut K; Chromik AM; Belyaev O; Muller CA; Uhl W; Tannapfel A; Schmidt WE
    Digestion; 2008; 78(1):60-5. PubMed ID: 18946221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis.
    Pfützer R; Myers E; Applebaum-Shapiro S; Finch R; Ellis I; Neoptolemos J; Kant JA; Whitcomb DC
    Gut; 2002 Feb; 50(2):271-2. PubMed ID: 11788572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations of the cationic trypsinogen gene in hereditary and non-hereditary pancreatitis.
    O'Reilly DA; Yang BM; Creighton JE; Demaine AG; Kingsnorth AN
    Digestion; 2001; 64(1):54-60. PubMed ID: 11549837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic Expression of PRSS1
    Huang H; Swidnicka-Siergiejko AK; Daniluk J; Gaiser S; Yao Y; Peng L; Zhang Y; Liu Y; Dong M; Zhan X; Wang H; Bi Y; Li Z; Ji B; Logsdon CD
    Gastroenterology; 2020 Mar; 158(4):1072-1082.e7. PubMed ID: 31419436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.